UnitedHealth Group is trading 8.1% up at $456.09 after reporting stronger-than-expected second quarter 2026 earnings and lifting its full-year adjusted EPS guidance to $19.50–$20.00.
- The company highlighted margin recovery, disciplined pricing, and favorable reserve development as key drivers for the quarter.
- All operating segments exceeded internal plans, fueling investor optimism despite broader weakness across the healthcare sector.